Institutions Holding Call Options on Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the call option holders of Regeneron Pharmaceuticals, Inc. (REGN). We have compiled data on the institutions that hold call options on the stock, with a total of 1.22 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $858 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Verition Fund Management LLC
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
3,700
calls
|
$2.6 Million
0.02% of portfolio
|
N/A
|
|
|
Capstone Investment Advisors, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
2,500
calls
|
$1.75 Million
0.01% of portfolio
|
N/A
|
|
|
Two Sigma Securities, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
2,500
calls
|
$1.75 Million
0.05% of portfolio
|
N/A
|
|
|
Nine Masts Capital LTD
|
Nov 12, 2024 Q3 2024 |
2,500
calls
|
$1.75 Million
0.77% of portfolio
|
N/A
|
|
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,700
calls
|
$1.19 Million
0.0% of portfolio
|
N/A
|
|
|
Wealth Enhancement Advisory Services, LLC
|
Oct 23, 2024 Q3 2024 |
900
calls
|
$631,665
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Centiva Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
600
calls
|
$421,110
0.01% of portfolio
|
N/A
|
|
|
Xr Securities LLC
|
Oct 25, 2024 Q3 2024 |
500
calls
|
$350,925
0.15% of portfolio
|
Q3 2024
Reduced 37.5%
|
|
|
Capula Management LTD
Grand Cayman, E9 |
Nov 13, 2024 Q3 2024 |
200
calls
|
$140,370
0.0% of portfolio
|
N/A
|